Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

CLGN
CollPlant Biotechnologies Ltd
stock NASDAQ

At Close
Aug 3, 2026 3:59:30 PM EDT
0.3120USD+14.370%(+0.0392)12,808
0.2600Bid   0.3800Ask   0.1200Spread
Pre-market
Aug 3, 2026 9:26:30 AM EDT
0.3193USD+17.045%(+0.0465)100
After-hours
Aug 3, 2026 4:00:30 PM EDT
0.3180USD+1.923%(+0.0060)126
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 5, 2022
07:01AM EST  CollPlant Issues Letter to Shareholders   PR Newswire
Dec 27, 2021
10:00AM EST  Shares of CollPlant Biotechnologies Ltd. (CLGN) are jumping over 20% on Monday morning despite no stock-related news to drive the shares.   RTTNews
Dec 2, 2021
07:12AM EST  CollPlant Announces Publication Highlighting Its rhCollagen-based Photocurable Dermal Filler In The Plastic And Reconstructive Surgery Journal   Benzinga
07:01AM EST  CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable   PR Newswire
Nov 18, 2021
07:33AM EST  CollPlant Biotechnologies Q3 EPS $(0.26) Down From $0.11 YoY   Benzinga
07:02AM EST  CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021   PR Newswire
Nov 15, 2021
07:01AM EST  CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D(tm)   PR Newswire
Oct 14, 2021
07:02AM EDT  CollPlant to Present at Dawson James Small Cap Growth Conference on October 21st   PR Newswire
Oct 11, 2021
07:01AM EDT  CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D   PR Newswire
Sep 30, 2021
07:01AM EDT  CollPlant to Present at Fall Harvest - Best Ideas from the Buy-Side on October   PR Newswire
Sep 27, 2021
07:01AM EDT  CollPlant CEO Yehiel Tal to Discuss Emerging Uses of rhCollagen in Aesthetic   PR Newswire
Sep 9, 2021
07:01AM EDT  CollPlant CEO Yehiel Tal elected to the Board of Directors of the International   PR Newswire
Sep 7, 2021
07:01AM EDT  CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference   PR Newswire
Aug 19, 2021
08:02AM EDT  CollPlant Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors   PR Newswire
07:51AM EDT  Recap: CollPlant Biotechnologies Q2 Earnings   Benzinga
07:19AM EDT  CollPlant Q2 GAAP Net Loss $3.0 Mln Or $0.3/Shr Vs Loss Of $2.0 Mln Or $0.28/Shr Last Year   RTTNews
07:04AM EDT  CollPlant Biotechnologies Q2 EPS $(0.25) Down From $(0.20) YoY, Sales $691.00K Down From $823.00K YoY   Benzinga
07:01AM EDT  CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021   PR Newswire
Aug 16, 2021
09:11AM EDT  Platform for 3D Bioprinting of Tissues and Organs at the Biomaterials For 3D Printing Webinar   PR Newswire
Jun 23, 2021
04:44AM EDT  44 Biggest Movers From Yesterday   Benzinga
Jun 22, 2021
10:20AM EDT  3D Systems Adds 10% On Deal With CollPlant Biotech   RTTNews
08:33AM EDT  3D Systems, CollPlant Report Co-Development Deal To Deliver Bioprinted Solutions For Improved Breast Reconstruction Treatments, No Terms Disclosed   Benzinga
08:30AM EDT  -- High resolution 3D bioprinted soft tissue matrix mimics patients anatomy, enables in-growth to facilitate healing and enhanced outcomes -- Unlimited supply of plant-based recombinant human collagen (rhCollagen) does not require animal or human sources to produce   GlobeNewswire Inc
Jun 4, 2021
07:11AM EDT  CollPlant Reports Uplisting To Nasdaq Will Occur at Market Open On Jun. 4   Benzinga
07:02AM EDT  CollPlant Announces Uplisting Of Its Ordinary Shares To The Nasdaq Global Select Market   RTTNews
07:01AM EDT  CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market(r);   PR Newswire
May 27, 2021
07:18AM EDT  CollPlant Biotechnologies Q1 EPS $0.88 Vs Loss $0.24 Last Year   RTTNews
07:08AM EDT  CollPlant Biotechnologies Q1 EPS $0.91 Up From $(0.21) YoY, Sales $14.50M Up From $609.00K YoY   Benzinga
07:01AM EDT  CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with   PR Newswire
May 25, 2021
09:16AM EDT  CollPlant Reports Its Shares Have Been Approved To Trade On Nasdaq Under Symbol 'CLGN,' Will Begin Trade As Of Jun. 4, 2021   Benzinga
09:02AM EDT  CollPlant Announces Uplisting to the Nasdaq Global Market(r) and Transition to   PR Newswire
Mar 29, 2021
07:25AM EDT  CollPlant Names Hugh Evans To Board   RTTNews
07:01AM EDT  CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of   PR Newswire
Mar 26, 2021
09:02AM EDT  CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year   PR Newswire
09:02AM EDT  CollPlant Biotechnologies FY20 EPS $(0.84), Up From $(2.23) YoY, Sales $6.1M, Up From $2.3M YoY   Benzinga
Mar 4, 2021
07:01AM EST  CollPlant To Present at the H.C. Wainwright Global Life Sciences Conference   PR Newswire
Feb 25, 2021
10:17AM EST  Mid-Morning Market Update: Markets Open Lower; Best Buy Posts Downbeat Sales   Benzinga
09:23AM EST  CollPlant Receives Notice From Lung Biotechnology On Termination Of Licensing Agreement   RTTNews
09:20AM EST  Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung   PR Newswire
Feb 18, 2021
09:34AM EST  CollPlant Biotech CEO Sends Letter To Shareholders   Benzinga
09:31AM EST  CollPlant Issues Letter to Shareholders   PR Newswire
07:00AM EST  CollPlant Biotechnologies (NASDAQ:CLGN),today announced that it has closed the previously announced registered direct offering for the purchase and sale of an aggregate of 2,000,000 of the Company's American Depositary Shares (ADSs), at a purchase price of$17.50per ADS.Each ADS represents one (1) ordinary share, par valueNIS 1.50per share, of CollPlant.   GlobeNewswire Inc
Feb 12, 2021
10:59AM EST  Mid-Morning Market Update: US Stock Futures Trend Down; Nasdaq Composite Dips 0.2%   Benzinga
09:57AM EST  Shares of CollPlant Biotechnologies Ltd. (CLGN) are trading down more than 29% Friday morning at $17.20.   RTTNews
05:53AM EST  CollPlant Priced Registered Direct Offering of 2M American Depositary Shares @$17.50/ADS   Benzinga
Feb 11, 2021
11:23PM EST  CollPlant Announces $35.0 Million Registered Direct Offering of   GlobeNewswire Inc
11:21AM EST  Stocks That Hit 52-Week Highs On Thursday   Benzinga
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
07:57AM EST  10 Biggest Price Target Changes For Tuesday   Benzinga
06:10AM EST  HC Wainwright & Co. Maintains Buy on CollPlant Biotechnologies, Raises Price Target to $26   Benzinga
Feb 8, 2021
10:00AM EST  CollPlant Biotechnologies Ltd. (CLGN) are currently gaining over 10% after the company said it entered into a worldwide exclusive development and commercialization agreement for dermal and soft tissue filler products with Allergan Aesthetics, an AbbVie company.   RTTNews
07:21AM EST  CollPlant In Deal With Allergan Aesthetics For RhCollagen In Dermal And Soft Tissue Filler Products   RTTNews
07:10AM EST  CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics for rhCollagen in Dermal and Soft Tissue Filler Products; CollPlant Will Receive An Upfront Payment Of $14M And Is Entitled To Receive Up To An Additional $89M In Milestone Payments   Benzinga
07:10AM EST  CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics for rhCollagen in Dermal and Soft Tissue Filler Products; CollPlant Will Receive An Upfront Payment Of $14M And Is Entitled To Receive Up To An Additional $89M   Benzinga
07:01AM EST  Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products   PR Newswire
Jan 29, 2021
07:45AM EST  The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO   Benzinga
Jan 28, 2021
08:03AM EST  The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO   Benzinga
Jan 27, 2021
08:38AM EST  3D Systems Reports Will 'Significantly' Expand Its Development Efforts Focused On Regenerative Medicine, Bioprinting Solutions; Says Decision Made Based On 'Tremendous' Progress Made In Collab With United Therapeutics   Benzinga
08:37AM EST  3D Systems Announces It Will 'significantly expand its development efforts focused on regenerative medicine and bioprinting solutions'   Benzinga
08:30AM EST  3D Systems Announces Breakthrough in Bioprinting Technology and   GlobeNewswire Inc
Dec 10, 2020
07:44AM EST  CollPlant And STEMCELL Technologies Enter Product Manufacturing And Supply Agreement   RTTNews
07:01AM EST  CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad   PR Newswire
Dec 1, 2020
07:53AM EST  CollPlant Q3 Revenues $4.1 Mln Vs $679K Last Year   RTTNews
07:15AM EST  CollPlant Biotechnologies Q3 Adj. EPS $0.11 Up From $(0.41) YoY, Sales $4.10M Up From $679.00K YoY   Benzinga
07:01AM EST  CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and   PR Newswire
Nov 10, 2020
07:00AM EST  CollPlant Announces Early Development Program of Antiviral Agent for Potential   PR Newswire
Oct 26, 2020
07:10AM EDT  CollPlan Receives First Significant Order for Vergenix, Worth 'Hundreds of Thousands of Dollars'   Benzinga
07:01AM EDT  CollPlant Receives Substantial First Order for its Vergenix(tm) Flowable Gel   PR Newswire
Oct 13, 2020
10:07AM EDT  CollPlant Biotechnologies Granted U.S. Patent Titled 'Cross-linked resilin-containing materials'   Benzinga
Sep 21, 2020
07:06AM EDT  United Therapeutics Exercises its Option for an Exclusive License to CollPlant's Technology for the 3D Bioprinting of Human Kidneys   Benzinga
07:01AM EDT  CollPlant and United Therapeutics Announce Exercise of Option that will Expand   PR Newswire
Sep 16, 2020
12:01PM EDT  Recombinant Human Collagen for Anti-Aging Therapies at the Science of Aging Virtual Symposium 2020   PR Newswire
Sep 14, 2020
07:22AM EDT  CollPlant Inks Deal For Distribution Of Vergenix Flowable Gel Product In Six CIS Countries   RTTNews
07:11AM EDT  CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States   Benzinga
07:01AM EDT  CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix   PR Newswire
Aug 31, 2020
07:01AM EDT  CollPlant Biotechnologies to Present at Science of Aging Virtual Symposium 2020   PR Newswire
Aug 28, 2020
07:03AM EDT  CollPlant Biotechnologies Q2 Adj. EPS $(0.20) Up From $(0.31) YoY, Sales $823.00K Up From $606.00K YoY   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC